Biognosys is a company that believes that deep proteome insights hold the key to breakthrough discoveries that transform science for better lives. The company’s versatile portfolio of next-generation proteomics solutions, including the TrueDiscovery™, TrueTarget™, and TrueSignature™ research service platforms, its flagship software Spectronaut®, and the PQ500™ kit, make the proteome actionable to empower research, drug development, and clinical decision-making. Biognosys’ solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. The company’s unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins with industry-leading precision, depth, and throughput. Through its strategic partnership with Bruker, Biognosys makes proteomics globally accessible.